IS6110-RFLP clustering patterns, spoligopatterns and drug resistance profiles of M. tuberculosis isolates.

Reduced NO susceptibility in spoligotype-based clusters of M. tuberculosis.

Jonna Idh (309557)
Mekidim Mekonnen (317585)
Ebba Abate (309550)
Wassihun Wedajo (317586)
Jim Werngren (217140)
Kristian Ängeby (317588)
Maria Lerm (150166)
Daniel Elias (309565)
Tommy Sundqvist (317591)
Abraham Aseffa (108981)
Olle Stendahl (179805)
Thomas Schön (309566)

February 2013

Survival of clinical isolates 24 hours after exposure to the NO donor DETA/NO. Presence of resist...

Resistance pattern, mutation, and amino acid change of drug-resistant M. tuberculosis isolates.

Melaku Tilahun (4857484)
Teklu Wegayehu (584051)
Biniam Wondale (4641961)
Tewdros Tariku Gebresilase (16954526)
Tesfaye Gebreyohannes (16954529)
Abraham Tekola (16954532)
Mekdes Alemu (16954535)
Sebsib Neway (13864176)
Bethlehem Adnew (15551564)
Maeruf Fetu Nassir (16954538)
Yonas Kassahun (8108099)
Abraham Aseffa (108981)
Kidist Bobosha (549886)

September 2023

Resistance pattern, mutation, and amino acid change of drug-resistant M. tuberculosis isolates.</p

Drug sensitivity pattern among category –I relapse cases of pulmonary tuberculosis and its correlation with pre- treatment sputum and radiological status

Narendra Kumar Narahari
Sudhir Kumar Vujhini

January 2016

Background: An increased incidence of drug resistance is seen even after active implementation of di...

Anti tuberculosis drug resistance pattern of Mycobacterium tuberculosis isolates.

Sayera Banu (131360)
Arman Hossain (316210)
Mohammad Khaja Mafij Uddin (316212)
Muhammad Reaj Uddin (364509)
Tahmeed Ahmed (176583)
Razia Khatun (316215)
Asif Mujtaba Mahmud (316207)
Khurshid Alam Hyder (364511)
Afzalunnessa Binte Lutfor (364512)
Md. Sirajul Karim (364513)
Khalequ Zaman (131356)
Md. Ashraful Islam Khan (364514)
Pravat Chandra Barua (364515)
Stephen P. Luby (174280)

February 2013

Anti tuberculosis drug resistance pattern of Mycobacterium tuberculosis isolates.</p

Classification of the patients according to drug resistance profiles against the four first-line tuberculosis drugs (H,E,R and S) at time of enrolment (T0).

Francine Matthys (340855)
Leen Rigouts (62768)
Vinciane Sizaire (80993)
Natalia Vezhnina (117175)
Maryvonne Lecoq (369121)
Vera Golubeva (369123)
Françoise Portaels (3213348)
Patrick Van der Stuyft (154687)
Michael Kimerling (232793)

February 2013

N = 233 H, Isoniazid; E, Ethambutol; R, Rifampicin; S, Streptomycin.*Poly-resistant TB def...

Molecular characterization, drug susceptibility profile, minimum inhibitory concentration, and drug interaction in the M. tuberculosis H37Rv reference strain and multidrug-resistant clinical isolates.

Fernanda de Oliveira Demitto (692933)
Renata Claro Ribeiro do Amaral (692934)
Flaviane Granero Maltempe (692935)
Vera Lúcia Dias Siqueira (692936)
Regiane Bertin de Lima Scodro (692937)
Mariana Aparecida Lopes (692938)
Katiany R. Caleffi-Ferracioli (692939)
Pedro Henrique Canezin (692940)
Rosilene Fressatti Cardoso (627646)

February 2015

R, resistant; NP, not performed; INH, isoniazid; RIF, rifampicin; EMB, ethambutol; PZA, pirazinam...

Frequency and patterns of resistance conferring mutations in M. tuberculosis isolates that were resistant to rifampicin (n = 45) and isoniazid (n = 50).

Edgar Kigozi (724127)
George W. Kasule (5318114)
Kenneth Musisi (440368)
Deus Lukoye (357718)
Samuel Kyobe (133439)
Fred Ashaba Katabazi (133433)
Eddie M. Wampande (5318117)
Moses L. Joloba (221691)
David Patrick Kateete (133432)

May 2018

Frequency and patterns of resistance conferring mutations in M. tuberculosis isolat...

Drug resistance pattern of M. tuberculosis in category II treatment failure pulmonary tuberculosis patients

Fahmida Rahman
Sadia Sharmin
Md. Mustafa Kamal
Md. Ruhul Amin Miah

January 2013

This study was designed to determine the extent of drug resistance of M. tuberculosis (MTB) isolated...

Drug resistance patterns of M. tuberculosis in the TB-HIV coinfection group and the TB without HIV infection group.

Mi Zhou (9884)
Shan Liu (193759)
Qingfeng Li (1524259)
Qiming Wang (730892)
Ma Zhu (6166328)
Ling Cao (304475)
Dongmei Wang (282313)
Yuanhong Xu (346563)
Tianli Zheng (6166331)
Qian Ye (610320)
Xiuying Hu (1379238)
Haojiang Zuo (5875103)
Xiaofang Pei (5875106)

December 2018

Drug resistance patterns of M. tuberculosis in the TB-HIV coinfection group and the TB without HIV i...

Resistance to first line anti-tuberculosis agents* amongst rifampicin susceptible Mycobacterium tuberculosis isolates.

Naima Fasih (296220)
Yasraba Rafiq (296222)
Kausar Jabeen (296224)
Rumina Hasan (73926)

February 2013

*Isoniazid (H); Pyrazinamide (Z); Ethambutol (E); Streptomycin (S).#Any resistance, either...

RESISTANCE PATTERNS IN PATIENTS OF DRUG RESISTANT PULMONARY TUBERCULOSIS

Yousaf Jamal
Jamal Ahmad
Afsar Ali
Mahmood Iqbal Malik
Sultan Mehmood Kamran
Wasim Alamgir

October 2019

Objective: To study the patterns of resistance to anti tuberculosis drugs in patients of drug resist...

THE PATTERN OF DRUG RESISTANCE AMONG NEWLY DIAGNOSED AND OLD CASES OF PULMONARY TUBERCULOSIS IN NRITLD

Seyed-davood Mansoori Md
Siamak Arami Md
Zahra Mirabolhasani Md
Paria Farnia Phd
Ali-akbar Velayati Md

March 2015

Background – Resistance to antituberculosis agents is an important obstacle in the treatment and con...

Emerg Infect Dis

In a tuberculosis (TB) program in the Central Penitentiary Hospital of Azerbaijan, we analyzed 65 is...

Simultaneous ethambutol & isoniazid resistance in clinical isolates of Mycobacterium tuberculosis

Pushpa Gupta
G. P. S. Jadaun
Ram Das
U. D. Gupta
Kiran Srivastava
Aradhana Chauhan
V. D. Sharma
D. S. Chauhan
V. M. Katoch

January 2004

Background & objectives: There is a need to understand the nature of drug resistance patterns an...

The frequency of non tuberculosis mycobacteria among isoniazid resistant Mycobacterium isolates and the pattern of resistance to antituberculosisdrugs

Perpustakaan UGM, i-lib

January 2010

ABSTRACT Non tuberculosis mycobacteria (NTM)could be the causative agents of various clinical infect...

Reduced NO susceptibility in spoligotype-based clusters of M. tuberculosis.

Jonna Idh (309557)
Mekidim Mekonnen (317585)
Ebba Abate (309550)
Wassihun Wedajo (317586)
Jim Werngren (217140)
Kristian Ängeby (317588)
Maria Lerm (150166)
Daniel Elias (309565)
Tommy Sundqvist (317591)
Abraham Aseffa (108981)
Olle Stendahl (179805)
Thomas Schön (309566)

February 2013

Survival of clinical isolates 24 hours after exposure to the NO donor DETA/NO. Presence of resist...

Resistance pattern, mutation, and amino acid change of drug-resistant M. tuberculosis isolates.

Melaku Tilahun (4857484)
Teklu Wegayehu (584051)
Biniam Wondale (4641961)
Tewdros Tariku Gebresilase (16954526)
Tesfaye Gebreyohannes (16954529)
Abraham Tekola (16954532)
Mekdes Alemu (16954535)
Sebsib Neway (13864176)
Bethlehem Adnew (15551564)
Maeruf Fetu Nassir (16954538)
Yonas Kassahun (8108099)
Abraham Aseffa (108981)
Kidist Bobosha (549886)

September 2023

Resistance pattern, mutation, and amino acid change of drug-resistant M. tuberculosis isolates.</p

Drug sensitivity pattern among category –I relapse cases of pulmonary tuberculosis and its correlation with pre- treatment sputum and radiological status

Narendra Kumar Narahari
Sudhir Kumar Vujhini

January 2016

Background: An increased incidence of drug resistance is seen even after active implementation of di...

Anti tuberculosis drug resistance pattern of Mycobacterium tuberculosis isolates.

Sayera Banu (131360)
Arman Hossain (316210)
Mohammad Khaja Mafij Uddin (316212)
Muhammad Reaj Uddin (364509)
Tahmeed Ahmed (176583)
Razia Khatun (316215)
Asif Mujtaba Mahmud (316207)
Khurshid Alam Hyder (364511)
Afzalunnessa Binte Lutfor (364512)
Md. Sirajul Karim (364513)
Khalequ Zaman (131356)
Md. Ashraful Islam Khan (364514)
Pravat Chandra Barua (364515)
Stephen P. Luby (174280)

February 2013

Anti tuberculosis drug resistance pattern of Mycobacterium tuberculosis isolates.</p

Classification of the patients according to drug resistance profiles against the four first-line tuberculosis drugs (H,E,R and S) at time of enrolment (T0).

Francine Matthys (340855)
Leen Rigouts (62768)
Vinciane Sizaire (80993)
Natalia Vezhnina (117175)
Maryvonne Lecoq (369121)
Vera Golubeva (369123)
Françoise Portaels (3213348)
Patrick Van der Stuyft (154687)
Michael Kimerling (232793)

February 2013

N = 233 H, Isoniazid; E, Ethambutol; R, Rifampicin; S, Streptomycin.*Poly-resistant TB def...

Molecular characterization, drug susceptibility profile, minimum inhibitory concentration, and drug interaction in the M. tuberculosis H37Rv reference strain and multidrug-resistant clinical isolates.

Fernanda de Oliveira Demitto (692933)
Renata Claro Ribeiro do Amaral (692934)
Flaviane Granero Maltempe (692935)
Vera Lúcia Dias Siqueira (692936)
Regiane Bertin de Lima Scodro (692937)
Mariana Aparecida Lopes (692938)
Katiany R. Caleffi-Ferracioli (692939)
Pedro Henrique Canezin (692940)
Rosilene Fressatti Cardoso (627646)

February 2015

R, resistant; NP, not performed; INH, isoniazid; RIF, rifampicin; EMB, ethambutol; PZA, pirazinam...

Frequency and patterns of resistance conferring mutations in M. tuberculosis isolates that were resistant to rifampicin (n = 45) and isoniazid (n = 50).

Edgar Kigozi (724127)
George W. Kasule (5318114)
Kenneth Musisi (440368)
Deus Lukoye (357718)
Samuel Kyobe (133439)
Fred Ashaba Katabazi (133433)
Eddie M. Wampande (5318117)
Moses L. Joloba (221691)
David Patrick Kateete (133432)

May 2018

Frequency and patterns of resistance conferring mutations in M. tuberculosis isolat...

Drug resistance pattern of M. tuberculosis in category II treatment failure pulmonary tuberculosis patients

Fahmida Rahman
Sadia Sharmin
Md. Mustafa Kamal
Md. Ruhul Amin Miah

January 2013

This study was designed to determine the extent of drug resistance of M. tuberculosis (MTB) isolated...

Drug resistance patterns of M. tuberculosis in the TB-HIV coinfection group and the TB without HIV infection group.

Mi Zhou (9884)
Shan Liu (193759)
Qingfeng Li (1524259)
Qiming Wang (730892)
Ma Zhu (6166328)
Ling Cao (304475)
Dongmei Wang (282313)
Yuanhong Xu (346563)
Tianli Zheng (6166331)
Qian Ye (610320)
Xiuying Hu (1379238)
Haojiang Zuo (5875103)
Xiaofang Pei (5875106)

December 2018

Drug resistance patterns of M. tuberculosis in the TB-HIV coinfection group and the TB without HIV i...

Resistance to first line anti-tuberculosis agents* amongst rifampicin susceptible Mycobacterium tuberculosis isolates.

Naima Fasih (296220)
Yasraba Rafiq (296222)
Kausar Jabeen (296224)
Rumina Hasan (73926)

February 2013

*Isoniazid (H); Pyrazinamide (Z); Ethambutol (E); Streptomycin (S).#Any resistance, either...

RESISTANCE PATTERNS IN PATIENTS OF DRUG RESISTANT PULMONARY TUBERCULOSIS

Yousaf Jamal
Jamal Ahmad
Afsar Ali
Mahmood Iqbal Malik
Sultan Mehmood Kamran
Wasim Alamgir

October 2019

Objective: To study the patterns of resistance to anti tuberculosis drugs in patients of drug resist...

THE PATTERN OF DRUG RESISTANCE AMONG NEWLY DIAGNOSED AND OLD CASES OF PULMONARY TUBERCULOSIS IN NRITLD

Seyed-davood Mansoori Md
Siamak Arami Md
Zahra Mirabolhasani Md
Paria Farnia Phd
Ali-akbar Velayati Md

March 2015

Background – Resistance to antituberculosis agents is an important obstacle in the treatment and con...

Emerg Infect Dis

In a tuberculosis (TB) program in the Central Penitentiary Hospital of Azerbaijan, we analyzed 65 is...

Simultaneous ethambutol & isoniazid resistance in clinical isolates of Mycobacterium tuberculosis

Pushpa Gupta
G. P. S. Jadaun
Ram Das
U. D. Gupta
Kiran Srivastava
Aradhana Chauhan
V. D. Sharma
D. S. Chauhan
V. M. Katoch

January 2004

Background & objectives: There is a need to understand the nature of drug resistance patterns an...

The frequency of non tuberculosis mycobacteria among isoniazid resistant Mycobacterium isolates and the pattern of resistance to antituberculosisdrugs

Perpustakaan UGM, i-lib

January 2010

ABSTRACT Non tuberculosis mycobacteria (NTM)could be the causative agents of various clinical infect...

Reduced NO susceptibility in spoligotype-based clusters of M. tuberculosis.

Jonna Idh (309557)
Mekidim Mekonnen (317585)
Ebba Abate (309550)
Wassihun Wedajo (317586)
Jim Werngren (217140)
Kristian Ängeby (317588)
Maria Lerm (150166)
Daniel Elias (309565)
Tommy Sundqvist (317591)
Abraham Aseffa (108981)
Olle Stendahl (179805)
Thomas Schön (309566)

February 2013

Survival of clinical isolates 24 hours after exposure to the NO donor DETA/NO. Presence of resist...

Resistance pattern, mutation, and amino acid change of drug-resistant M. tuberculosis isolates.

Melaku Tilahun (4857484)
Teklu Wegayehu (584051)
Biniam Wondale (4641961)
Tewdros Tariku Gebresilase (16954526)
Tesfaye Gebreyohannes (16954529)
Abraham Tekola (16954532)
Mekdes Alemu (16954535)
Sebsib Neway (13864176)
Bethlehem Adnew (15551564)
Maeruf Fetu Nassir (16954538)
Yonas Kassahun (8108099)
Abraham Aseffa (108981)
Kidist Bobosha (549886)

September 2023

Resistance pattern, mutation, and amino acid change of drug-resistant M. tuberculosis isolates.</p

Drug sensitivity pattern among category –I relapse cases of pulmonary tuberculosis and its correlation with pre- treatment sputum and radiological status

Narendra Kumar Narahari
Sudhir Kumar Vujhini

January 2016

Background: An increased incidence of drug resistance is seen even after active implementation of di...

IS6110-RFLP clustering patterns, spoligopatterns and drug resistance profiles of <i>M. tuberculosis</i> isolates.

Abstract

Extracted data

IS6110-RFLP clustering patterns, spoligopatterns and drug resistance profiles of <i>M. tuberculosis</i> isolates.

Abstract

Extracted data

Related items

Related items